On the stock market since 2025, it operates in the everyday-essentials business. It has 96 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
An average decline of 13% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
An investor who bought at the very peak is down 95% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $6.7M a year. A small number, but proof the product has real buyers.
A loss of $397K against $6.7M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts about 1.7 years. After that, the company needs to find new money.
On our five-subject report card, RYET sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RYET is a high-risk stock — not yet profitable, and its future rides on its product catching on.